Utilization of <scp>real‐world</scp> data in assessing treatment effectiveness for diffuse large <scp>B‐cell</scp> lymphoma-Reference-Cited by-同舟云学术

Utilization of real‐world data in assessing treatment effectiveness for diffuse large B‐cell lymphoma

Published:2022-10-31 Issue:1 Volume:98 Page:180-192
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:American J Hematol

Author:

Nowakowski Grzegorz¹^ORCID,Maurer Matthew J.¹^ORCID,Cerhan James R.²^ORCID,Dey Debarshi³^ORCID,Sehn Laurie H.⁴^ORCID

Affiliation:

1. Division of Hematology Mayo Clinic Rochester Minnesota USA

2. Department of Quantitative Health Sciences Mayo Clinic Rochester Minnesota USA

3. MorphoSys AG Planegg Germany

4. BC Cancer Centre for Lymphoid Cancer and the University of British Columbia Vancouver Canada

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.26767

Reference110 articles.

1. Epidemiology of non‐Hodgkin's lymphomas;García Zueco JC;Sangre (Barc),1994

2. IDEC-C2B8 (Rituximab) Anti-CD20 Monoclonal Antibody Therapy in Patients With Relapsed Low-Grade Non-Hodgkin's Lymphoma

3. Rituximab in B-Cell Hematologic Malignancies: A Review of 20 Years of Clinical Experience

4. Referenced with permission from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for B‐Cell Lymphomas V.5.2022. © National Comprehensive Cancer Network Inc. 2022. All rights reserved. Accessed October 1 2022. To view the most recent and complete version of the guideline go online to NCCN.org. NCCN makes no warranties of any kind whatsoever regarding their content use or application and disclaims any responsibility for their application or use in any way.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Utilization of Real-World Data to Facilitate Clinical Trials for Patients with Lymphoma;Pharmacoepidemiology;2024-08-06

2. Comparison of Vital Status, Cause of Death, and Follow-Up after Hematopoietic Cell Transplantation in Linked Center for International Blood and Marrow Transplant Research and California Cancer Registry Data, 1991 to 2018;Transplantation and Cellular Therapy;2024-02

3. Challenges for quality and utilization of real-world data for diffuse large B-cell lymphoma in REALYSA, a LYSA cohort;Blood Advances;2024-01-10

4. Efficacy of chimeric antigen receptor T cell therapy and autologous stem cell transplant in relapsed or refractory diffuse large B-cell lymphoma: A systematic review;Frontiers in Immunology;2023-01-17